| Mark A Coll, OD | |
|
3720 N Josey Ln Ste 114, Carrollton, TX 75007-2470 | |
| (972) 395-8434 | |
| (972) 395-8433 |
| Full Name | Mark A Coll |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 33 Years |
| Location | 3720 N Josey Ln Ste 114, Carrollton, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124103759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4443T (Texas) | Primary |
| 152WC0802X | Optometrist - Corneal And Contact Management | 4443T (Texas) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kenneth I Uzick Od Pc | 0244303717 | 2 |
News Archive
John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.
Scientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate new risk genes for osteoporosis, the chronic bone-weakening condition that affects millions of people.
Repeated concussions or other mild traumatic brain injuries can lead to prolonged symptoms and impaired quality of life.
The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or biologics.
Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified - and ultimately treated.
› Verified 5 days ago
| Provider Name | Kenneth I Uzick Od Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235148560 PECOS PAC ID: 0244303717 Enrollment ID: O20080716000324 |
News Archive
John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.
Scientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate new risk genes for osteoporosis, the chronic bone-weakening condition that affects millions of people.
Repeated concussions or other mild traumatic brain injuries can lead to prolonged symptoms and impaired quality of life.
The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or biologics.
Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified - and ultimately treated.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark A Coll, OD 3611 Foxboro Ln, Carrollton, TX 75007-2937 Ph: (972) 492-6920 | Mark A Coll, OD 3720 N Josey Ln Ste 114, Carrollton, TX 75007-2470 Ph: (972) 395-8434 |
News Archive
John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.
Scientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate new risk genes for osteoporosis, the chronic bone-weakening condition that affects millions of people.
Repeated concussions or other mild traumatic brain injuries can lead to prolonged symptoms and impaired quality of life.
The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or biologics.
Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified - and ultimately treated.
› Verified 5 days ago
Infinity Vision Associates Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 4009 Old Denton Rd, Suite 124, Carrollton, TX 75007 Phone: 972-939-6567 Fax: 972-939-6268 | |
J&jkim Vision Associates, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2625 Old Denton Rd Ste 422, Carrollton, TX 75007 Phone: 972-245-5099 | |
Need Eye Exam Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 2532 Old Denton Rd Unit 103, Carrollton, TX 75006 Phone: 469-469-1338 Fax: 972-292-9969 | |
Contact Lens Center Inc Optometrist Medicare: Medicare Enrolled Practice Location: 1514 E Belt Line Rd, Carrollton, TX 75006 Phone: 972-242-2020 Fax: 972-242-2020 | |
Dr. Mary Anne Peck, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3012 E. Hebron Parkway, Suite 100, Carrollton, TX 75010 Phone: 972-307-5000 Fax: 972-307-7717 | |
Lisa Park, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1428 W Hebron Pkwy Ste 125, Carrollton, TX 75010 Phone: 972-325-2022 |